Wird geladen...
Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective
Fragile X syndrome (FXS) is the leading known cause of inherited intellectual disability and autism spectrum disorder. It is caused by a mutation of the fragile X mental retardation 1 (FMR1) gene, resulting in a deficit of fragile X mental retardation protein (FMRP). The clinical presentation of FXS...
Gespeichert in:
| Veröffentlicht in: | Brain Sci |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6315847/ https://ncbi.nlm.nih.gov/pubmed/30563047 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/brainsci8120214 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|